1-4 of 4
Estella Mendelson, BSRN, MBA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Increased Eligibility for Attempting Treatment-Free Remission (TFR) with Frontline Nilotinib (NIL) vs Imatinib (IM) in Patients with Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia (CML): Results of a Stochastic Simulation Model

Francois-Xavier Mahon, MD PhD Professor, An Tran-Duy, Raechelle G. Ocampo, David Ray, PharmD, MBA, Estella Mendelson, BSRN, MBA, Aby Buchbinder, Pascal Edrich, Sonya J. Snedecor, PhD, Giuseppe Saglio
Journal: Blood
Blood (2015) 126 (23): 5154.
https://doi.org/10.1182/blood.V126.23.5154.5154
Published: 2015
Journal Articles

Early Molecular Response (EMR) with Frontline Treatment Is a Significant Predictor of Long-Term BCR-ABL Transcript Levels in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML) in Chronic Phase

Giuseppe Saglio, Sonya J. Snedecor, PhD, Xiang Ji, Ming-Hui Tai, BPharm, MHPA, PhD, David Ray, PharmD, MBA, Estella Mendelson, BSRN, MBA, Aby Buchbinder, Pascal Edrich, Francois-Xavier Mahon, MD PhD Professor
Journal: Blood
Blood (2015) 126 (23): 1579.
https://doi.org/10.1182/blood.V126.23.1579.1579
Published: 2015
Journal Articles

Attitudes and Perceptions of Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Toward Treatment-Free Remission (TFR)

Carla Maria Boquimpani, MD, Tomasz Szczudlo, MD, Estella Mendelson, BSRN, MBA, Katy Benjamin, PhD, Tamás Masszi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4547.
https://doi.org/10.1182/blood.V124.21.4547.4547
Published: 2014
Journal Articles

Real-World Assessment of Clinical Outcomes in Lower-Risk Myelofibrosis Patients Receiving Treatment with Ruxolitinib

Keith L Davis, MA, James A. Kaye, MD DrPH, Isabelle Cote, PhD, Haitao Gao, Julian Perez Ronco, MD, Raafat Seifeldin, Pharm D, MS, PhD, Estella Mendelson, BSRN, MBA
Journal: Blood
Blood (2014) 124 (21): 1857.
https://doi.org/10.1182/blood.V124.21.1857.1857
Published: 2014